Effect of Intramuscular Midazolam Premedication on Patient Satisfaction in Women Undergoing General Anaesthesia: a Randomised Control Trial
Overview
Affiliations
Objective: To determine the effect of premedication with intramuscular midazolam on patient satisfaction in women undergoing general anaesthesia.
Trial Design, Setting And Participants: Double-blind, parallel randomised control trial at a tertiary care medical centre in South Korea. Initially, 140 women aged 20-65 years who underwent general anaesthesia and had an American Society of Anesthesiology physical status classification of I or II were randomly assigned to the intervention group or the control group, and 134 patients (intervention n=65; control n=69) completed the study.
Intervention: Intramuscular administration of midazolam (0.05 mg/kg) or placebo (normal saline 0.01 mL/kg) on arrival at the preoperative holding area.
Main Outcomes: The primary outcome was the patient's overall satisfaction with the anaesthesia experience as determined by questionnaire responses on the day after surgery. Satisfaction was defined as a response of 3 or 4 on a five-point scale (0-4). The secondary outcomes included blood pressure, heart rate, oxygen desaturation, recovery duration and postoperative pain.
Results: Patients who received midazolam were more satisfied than those who received placebo (percentage difference: 21.0%, OR 3.56, 95% CI 1.46 to 8.70). A subgroup analysis revealed that this difference was greater in patients with anxiety, defined as those whose Amsterdam Preoperative Anxiety and Information Scale anxiety score was ≥11, than that for the whole sample population (percentage difference: 24.0%, OR 4.33, 95% CI 1.25 to 14.96). Both groups had similar heart rates, blood pressure and oxygen desaturation.
Conclusion: Intramuscular administration of midazolam in women before general anaesthesia in the preoperative holding area improved self-reported satisfaction with the anaesthesia experience, with an acceptable safety profile.
Trial Registration Number: KCT0006002.
Linassi F, Zanatta P, Kreuzer M, Ciavattini E, Rizzetto C, Carron M Life (Basel). 2025; 15(2).
PMID: 40003628 PMC: 11856711. DOI: 10.3390/life15020219.
Pharmacokinetic-Pharmacodynamic Modeling of Midazolam in Pediatric Surgery.
Flores-Perez C, Moreno-Rocha L, Chavez-Pacheco J, Noguez-Mendez N, Flores-Perez J, Ortiz-Marmolejo D Pharmaceutics. 2023; 15(11).
PMID: 38004544 PMC: 10674765. DOI: 10.3390/pharmaceutics15112565.
Modulating Influence of State Anxiety on the Effect of Midazolam on Postsurgical Pain.
Dahlem C, Monteiro C, Mendes E, Martinho J, Oliveira C, Bettencourt M J Clin Med. 2023; 12(7).
PMID: 37048752 PMC: 10095355. DOI: 10.3390/jcm12072669.